Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages. [electronic resource]
Producer: 20070419Description: 134-40 p. digitalISSN:- 1043-4666
- Animals
- Bacterial Proteins -- genetics
- Captopril -- analogs & derivatives
- Cell Line
- Gene Expression -- drug effects
- Interferon-gamma -- pharmacology
- Macrophages -- drug effects
- Membrane Glycoproteins -- genetics
- Mice
- Microbial Viability -- drug effects
- Mutation
- NADPH Oxidase 2
- NADPH Oxidases -- genetics
- RNA, Messenger -- genetics
- Reactive Oxygen Species -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Salmonella typhimurium -- drug effects
- Vasoactive Intestinal Peptide -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.